Tag: shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Summa Defence Plc
Company announcement, Major holdings        10 June 2025 at 5.00 p.m. (CEST)

Growing Demand and a Maturing Technological Landscape That is Fostering Scalability and Affordability in HPQ Production

June 10, 2025
Announcement no. 16

CAMBRIDGE, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced a reverse stock split of its issued and outstanding shares of common stock, par value $0.005 per share (the “Common Stock”), at a ratio of 1-for-15, effective June 12, 2025 at 12:01 a.m. Eastern Time. The Company’s Common Stock is expected to begin trading on a split-adjusted basis when the market opens on June 12, 2025, under the existing trading symbol “ERNA.”

In week 23 Kvika banki hf. („Kvika“ or „the bank“) purchased 16,200,000 of its own shares at the purchase price ISK 287,285,000. See further details below:

TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Timbercreek Financial Corp. (TSX: TF) (the "Company") announced today that it has obtained the approval of the Toronto Stock Exchange (the "TSX") to commence a normal course issuer bid (the “NCIB”) with respect to its common shares (the “Shares”). The NCIB will commence on June 12, 2025 and will terminate on the earlier of June 11, 2026 or the date on which the Company has purchased the maximum number of Shares permitted under the NCIB.